ACTA NEUROPHARMACOLOGICA ›› 2026, Vol. 16 ›› Issue (2): 12-.DOI: 10.3969/j.issn.2095-1396.2026.02.002

    Next Articles

Study Regarding the Mechanism of Buxue Tongluo Pill Against Osteonecrosis of Femoral Head Based on Network Pharmacology and Transcriptomics

WANG Dan, LI Guo-qing, GONG Mi-mi, LIU Wu-jiang, LI Hui-xuan, SHAO Xiu-li, ZHANG Hua-lin   

  1. 1. The Hospital of 81st Group Army PLA, Zhangjiakou, 075000, China 

    2. Zhangjiakou First Hospital, Zhangjiakou, 075000, China

  • Online:2026-04-30 Published:2026-06-16

Abstract:

Objective: To investigate the preventive mechanism of Buxue Tongluo pill(BTP) against osteonecrosis of femoral head(ONFH) based on network pharmacology and transcriptomics. Methods: We established an ONFH model in SD rats using high dose dexamethasone. Thirty-six rats were randomly divided into six groups, namely normal group, model group, positive group and low-dose group, middle-dose group and high-dose group. Transcriptome sequencing regarding the femoral head was conducted 4 weeks after continuous treatment. Subsequently, mechanism of action of BTP on ONFH determined by integrated network pharmacology. Results: After BTP treatment, 308 genes were significant changed in expression levels, 120 genes being up-regulated and 188 being down-regulated. A total of 108 key targets were targeted for selection. KEGG analysis suggested that various pathways were largely involved in the mechanisms of BTP against ONFH, such as PI3k-Akt signal pathway, cancer, cell cycle and so on. Conclusion: BTP is effective in treating ONFH through multi-components, multi-targets and multi-channels, which may be related to apoptosis mediated by PI3k-Akt signaling pathway.

Key words: Buxue Tongluo pill, transcriptome sequencing, network pharmacology, osteonecrosis of femoral head

CLC Number: